-
E-mail
yilaibo@shyilaibo.com
-
Phone
15221734409
-
Address
B650, Block B, No. 180 Changjiang South Road, Baoshan District, Shanghai
Ilebo Biotechnology (Shanghai) Co., Ltd
yilaibo@shyilaibo.com
15221734409
B650, Block B, No. 180 Changjiang South Road, Baoshan District, Shanghai
The process by which a specific gene transitions from a silent state to an expressed state, throughInitiate transcriptionRealize the transformation of genetic information into functional molecules (RNA/protein). Its key features include:
Spatiotemporal specificityTriggered under specific cell types, developmental stages, or environmental signals.
Cascading regulationA cascade reaction that relies on signal transduction transcription factors DNA elements.
dynamic equilibriumMaintaining cellular functional homeostasis in conjunction with gene silencing.
core valueDrive developmental differentiation (such as early embryonic genome activation), environmental adaptation (such as low phosphorus induced one foot lactone pathway), and disease occurrence (such as abnormal activation of oncogenes).
| component | function | mechanism of action |
|---|---|---|
| promoter | Basic regions for recruiting RNA polymerase | Provide transcription start sites (TSS) containing conserved sequences such as TATA frames |
| enhancer | Remote regulation of transcription efficiency | Forming spatial interactions with promoters (circular or linked models) to enhance the stability of transcriptional complexes |
| insulator | Block enhancer interference | Isolate chromatin domains to ensure specific activation of target genes |
Combined mode:
Transcription factors recognize specific sequences (such as promoters/enhancers) through DNA binding domains (such as zinc fingers, helix loop helices).
activation mechanism:
Recruitment ModelActivation factors directly bind to transcription machines (such as TFIID, RNA polymerase II) to accelerate complex assembly.
chromatin remodelingHistone acetyltransferases (HATs) modify chromatin and depolymerize nucleosome structures.
synergy:
Multiple activating factors combine to form 'enhanceres', achieving signal integration (such as interferon requiring synergy of 8 factors).
Image: Activation factor bridging DNA and transcription complex(Based on FIG.13.5)
DNA sequence → Activation factor binding → Recruitment of universal transcription factors → RNA polymerase assembly → Transcription initiation
DNA demethylation:
TET enzyme catalyzes 5mC → 5hmC to relieve transcriptional repression (such as Oct4 during embryonic development).
histone modification:
Activation markers: H3K4me3 and H3K27ac are enriched in promoters/enhancers.
Inhibition marker erasure: Histone demethylases (such as KDM4) remove silencing markers such as H3K9me3.
Chromatin conformational changes:
Enhancers promoters physically approach each other through the chromatin loop, activating genes such as the β - globin locus.
Classic Path:
Ligands (such as hormones) → membrane receptors (such as tyrosine kinase) → intracellular kinase cascade (MAPK/PI3K) → transcription factor phosphorylation → nuclear activation of target genes.
exampleHER2/neu oncogene amplification leads to continuous activation of receptors, which drives the proliferation of breast cancer.
Nuclear receptor pathway:
Liposoluble signals (such as steroid hormones) → bind to nuclear receptors → directly regulate DNA transcription.
low phosphorus stress:
Phosphorus starvation signal → activation of the synthesis gene of monocotyledonous lactone (SL) → accumulation of SL hormones → induction of auxin transporter expression → remodeling of rice root structure.
Symbiotic signal:
Orchid root fungi secrete CSG factors → activate calcium oscillation signals → induce symbiotic related genes (such as RAM1) → promote nutrient exchange.
Embryonic Genome Activation (EGA):
Homozygous gene silencing → degradation of maternal factors → zygoteGene J activity(Chromatin remodeling+synthesis of new transcription factors required).
critical incidentMouse 2-cell phase initiates primary EGA, but incorrect activation leads to implantation failure.
| Disease type | Abnormal activation mechanism | Pathological effects |
|---|---|---|
| cancer | Cancer gene amplification (HER2) or mutation (RAS) | Continuous proliferation signal |
| autoimmune disease | Excessive activation of immune genes by inflammatory factors | Attacking one's own organization |
| neurodegeneration | Abnormal activation of tau protein gene by stress signals | Neurofibrillary tangles |